Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

Effects of risk genes on BOLD activation in presymptomatic carriers of familial Alzheimer's disease mutations during a novelty encoding task.

Ringman JM, Medina LD, Braskie M, Rodriguez-Agudelo Y, Geschwind DH, Macias-Islas MA, Cummings JL, Bookheimer S.

Cereb Cortex. 2011 Apr;21(4):877-83. doi: 10.1093/cercor/bhq158. Epub 2010 Aug 20.

2.

Increased functional brain response during word retrieval in cognitively intact older adults at genetic risk for Alzheimer's disease.

Wierenga CE, Stricker NH, McCauley A, Simmons A, Jak AJ, Chang YL, Delano-Wood L, Bangen KJ, Salmon DP, Bondi MW.

Neuroimage. 2010 Jul 1;51(3):1222-33. doi: 10.1016/j.neuroimage.2010.03.021. Epub 2010 Mar 16.

3.

Functional alterations in memory networks in early Alzheimer's disease.

Sperling RA, Dickerson BC, Pihlajamaki M, Vannini P, LaViolette PS, Vitolo OV, Hedden T, Becker JA, Rentz DM, Selkoe DJ, Johnson KA.

Neuromolecular Med. 2010 Mar;12(1):27-43. doi: 10.1007/s12017-009-8109-7. Review.

4.

Impairment and compensation coexist in amnestic MCI default mode network.

Qi Z, Wu X, Wang Z, Zhang N, Dong H, Yao L, Li K.

Neuroimage. 2010 Mar;50(1):48-55. doi: 10.1016/j.neuroimage.2009.12.025. Epub 2009 Dec 16.

PMID:
20006713
5.

Cortical thickness analysis to detect progressive mild cognitive impairment: a reference to Alzheimer's disease.

Julkunen V, Niskanen E, Muehlboeck S, Pihlajamäki M, Könönen M, Hallikainen M, Kivipelto M, Tervo S, Vanninen R, Evans A, Soininen H.

Dement Geriatr Cogn Disord. 2009;28(5):404-12. doi: 10.1159/000256274. Epub 2009 Nov 10.

6.

Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease.

Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, Combarros O, Zelenika D, Bullido MJ, Tavernier B, Letenneur L, Bettens K, Berr C, Pasquier F, Fiévet N, Barberger-Gateau P, Engelborghs S, De Deyn P, Mateo I, Franck A, Helisalmi S, Porcellini E, Hanon O; European Alzheimer's Disease Initiative Investigators., de Pancorbo MM, Lendon C, Dufouil C, Jaillard C, Leveillard T, Alvarez V, Bosco P, Mancuso M, Panza F, Nacmias B, Bossù P, Piccardi P, Annoni G, Seripa D, Galimberti D, Hannequin D, Licastro F, Soininen H, Ritchie K, Blanché H, Dartigues JF, Tzourio C, Gut I, Van Broeckhoven C, Alpérovitch A, Lathrop M, Amouyel P.

Nat Genet. 2009 Oct;41(10):1094-9. doi: 10.1038/ng.439. Epub 2009 Sep 6.

PMID:
19734903
7.

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease.

Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Morgan K, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Holmes C, Mann D, Smith AD, Love S, Kehoe PG, Hardy J, Mead S, Fox N, Rossor M, Collinge J, Maier W, Jessen F, Schürmann B, Heun R, van den Bussche H, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frölich L, Hampel H, Hüll M, Rujescu D, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Sleegers K, Bettens K, Engelborghs S, De Deyn PP, Van Broeckhoven C, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Mühleisen TW, Nöthen MM, Moebus S, Jöckel KH, Klopp N, Wichmann HE, Carrasquillo MM, Pankratz VS, Younkin SG, Holmans PA, O'Donovan M, Owen MJ, Williams J.

Nat Genet. 2009 Oct;41(10):1088-93. doi: 10.1038/ng.440. Epub 2009 Sep 6. Erratum in: Nat Genet. 2009 Oct;41(10):1156. Nat Genet. 2013 Jun;45(6):712. Haun, Reinhard [added].

8.

CNS activation and regional connectivity during pantomime observation: no engagement of the mirror neuron system for deaf signers.

Emmorey K, Xu J, Gannon P, Goldin-Meadow S, Braun A.

Neuroimage. 2010 Jan 1;49(1):994-1005. doi: 10.1016/j.neuroimage.2009.08.001. Epub 2009 Aug 11.

9.

Evidence of altered posteromedial cortical FMRI activity in subjects at risk for Alzheimer disease.

Pihlajamäki M, O' Keefe K, Bertram L, Tanzi RE, Dickerson BC, Blacker D, Albert MS, Sperling RA.

Alzheimer Dis Assoc Disord. 2010 Jan-Mar;24(1):28-36. doi: 10.1097/WAD.0b013e3181a785c9.

10.

Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele.

Filippini N, MacIntosh BJ, Hough MG, Goodwin GM, Frisoni GB, Smith SM, Matthews PM, Beckmann CF, Mackay CE.

Proc Natl Acad Sci U S A. 2009 Apr 28;106(17):7209-14. doi: 10.1073/pnas.0811879106. Epub 2009 Apr 8.

11.

Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI).

Langbaum JB, Chen K, Lee W, Reschke C, Bandy D, Fleisher AS, Alexander GE, Foster NL, Weiner MW, Koeppe RA, Jagust WJ, Reiman EM; Alzheimer's Disease Neuroimaging Initiative..

Neuroimage. 2009 May 1;45(4):1107-16. doi: 10.1016/j.neuroimage.2008.12.072. Epub 2009 Jan 21.

12.

In vivo mapping of incremental cortical atrophy from incipient to overt Alzheimer's disease.

Frisoni GB, Prestia A, Rasser PE, Bonetti M, Thompson PM.

J Neurol. 2009 Jun;256(6):916-24. doi: 10.1007/s00415-009-5040-7. Epub 2009 Feb 28.

PMID:
19252794
13.

The influence of parental history of Alzheimer's disease and apolipoprotein E epsilon4 on the BOLD signal during recognition memory.

Xu G, McLaren DG, Ries ML, Fitzgerald ME, Bendlin BB, Rowley HA, Sager MA, Atwood C, Asthana S, Johnson SC.

Brain. 2009 Feb;132(Pt 2):383-91. doi: 10.1093/brain/awn254. Epub 2008 Oct 1.

14.

Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses.

Bertram L, Tanzi RE.

Nat Rev Neurosci. 2008 Oct;9(10):768-78. doi: 10.1038/nrn2494. Review.

PMID:
18802446
15.

Hippocampal hyperperfusion in Alzheimer's disease.

Alsop DC, Casement M, de Bazelaire C, Fong T, Press DZ.

Neuroimage. 2008 Oct 1;42(4):1267-74. doi: 10.1016/j.neuroimage.2008.06.006. Epub 2008 Jun 17.

16.

Evidence of neurodegeneration in brains of older adults who do not yet fulfill MCI criteria.

Chao LL, Mueller SG, Buckley ST, Peek K, Raptentsetseng S, Elman J, Yaffe K, Miller BL, Kramer JH, Madison C, Mungas D, Schuff N, Weiner MW.

Neurobiol Aging. 2010 Mar;31(3):368-77. doi: 10.1016/j.neurobiolaging.2008.05.004. Epub 2008 Jun 11.

17.

fMRI activation during episodic encoding and metacognitive appraisal across the lifespan: risk factors for Alzheimer's disease.

Trivedi MA, Schmitz TW, Ries ML, Hess TM, Fitzgerald ME, Atwood CS, Rowley HA, Asthana S, Sager MA, Johnson SC.

Neuropsychologia. 2008;46(6):1667-78. doi: 10.1016/j.neuropsychologia.2007.11.035. Epub 2007 Dec 17.

18.

Cerebral perfusion correlates of conversion to Alzheimer's disease in amnestic mild cognitive impairment.

Caroli A, Testa C, Geroldi C, Nobili F, Barnden LR, Guerra UP, Bonetti M, Frisoni GB.

J Neurol. 2007 Dec;254(12):1698-707. Epub 2007 Nov 9.

PMID:
17990057
19.

Hippocampal activation in adults with mild cognitive impairment predicts subsequent cognitive decline.

Miller SL, Fenstermacher E, Bates J, Blacker D, Sperling RA, Dickerson BC.

J Neurol Neurosurg Psychiatry. 2008 Jun;79(6):630-5. Epub 2007 Sep 10.

20.

Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations.

Ringman JM, O'Neill J, Geschwind D, Medina L, Apostolova LG, Rodriguez Y, Schaffer B, Varpetian A, Tseng B, Ortiz F, Fitten J, Cummings JL, Bartzokis G.

Brain. 2007 Jul;130(Pt 7):1767-76. Epub 2007 May 23.

PMID:
17522104

Supplemental Content

Support Center